Cash and cash equivalents were $2.3M as of December 31, 2022, compared to $12.7M as of December 31, 2021.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ACER:
- Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
- Biotech Alert: Searches spiking for these stocks today
- Acer Therapeutics: Data presented at SIMD on Urea Cycle Disorders
- Acer Therapeutics Announces Data Presented at Society for Inherited Metabolic Disorders Annual Meeting Identifying Preferred Urea Cycle Disorder Treatment Attributes
- Acer Therapeutics prices $2.68M registered direct offering